Table 2 Efficacy outcomes
Indicator/group | Group 1 | Group 2 | Group 3 |
|---|---|---|---|
Nalbuphine consumption during first 24 h after surgery, mg | 0 [0–5] | 15 [10–20]3 | 20 [15–25]3 |
Total nalbuphine consumption during hospitalization, mg | 5 [0–10] | 45 [40–50] | 50 [40–60] |
Pain at rest in the first 24 h after surgery, NPRS | 3 [2–4] | 5 [3–6] | 6 [4–7] |
Pain during movements in the first 24 h after surgery, NPRS | 4 [3–5] | 6 [4–7] | 7 [5–8] |
Number of patients with severe pain, n (%) | 3/27 (10)1 | 14/16 (47) | 18/12 (60)1 |
Analgesia on-demand, n | 0 [0–1]1 | 3 [2–4] | 4 [3–4] |
Sleep quality (0 to 10) | 8 [7–9]1 | 6 [5–7] | 4 [3–5] |
Mobilization (sitting) on 1st day, n (%) | 20/10 (67)2 | 10/20 (33) | 3/27 (10) |
Mobilization (getting up) on 1st day, n (%) | 4/26 (13) | 0/30 | 0/30 |
Mobilization (sitting) on 2nd days, n (%) | 29/1 (3) | 25/5 (83) | 20/10 (67)1 |
Mobilization (getting up) on 2nd days, n (%) | 27/3 (90)2 | 10/20 (33) | 8/22 (27) |